The Discounted Cash Flow (DCF) valuation of Harbin Gloria Pharmaceuticals Co Ltd (002437.SZ) is 1.58 CNY. With the latest stock price at 2.94 CNY, the upside of Harbin Gloria Pharmaceuticals Co Ltd based on DCF is -46.2%.
Based on the latest price of 2.94 CNY and our DCF valuation, Harbin Gloria Pharmaceuticals Co Ltd (002437.SZ) is a sell. selling 002437.SZ stocks now will result in a potential gain of 46.2%.
| Range | Selected | |
| WACC / Discount Rate | 8.4% - 11.2% | 9.8% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 1.24 - 2.34 | 1.58 |
| Upside | -57.8% - -20.5% | -46.2% |